Your browser doesn't support javascript.
loading
Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
Casadei-Gardini, Andrea; Scartozzi, Mario; Tada, Toshifumi; Yoo, Changhoon; Shimose, Shigeo; Masi, Gianluca; Lonardi, Sara; Frassineti, Luca Giovanni; Nicola, Silvestris; Piscaglia, Fabio; Kumada, Takashi; Kim, Hyung-Don; Koga, Hironori; Vivaldi, Caterina; Soldà, Caterina; Hiraoka, Atsushi; Bang, Yeonghak; Atsukawa, Masanori; Torimura, Takuji; Tsuj, Kunihiko; Itobayashi, Ei; Toyoda, Hidenori; Fukunishi, Shinya; Rimassa, Lorenza; Rimini, Margherita; Cascinu, Stefano; Cucchetti, Alessandro.
Afiliação
  • Casadei-Gardini A; Vita-Salute San Rafaele University, Milan, Italy.
  • Scartozzi M; Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy.
  • Tada T; Department of Medical Oncology, University Hospital of Cagliari, Cagliari, Italy.
  • Yoo C; Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
  • Shimose S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Masi G; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Lonardi S; Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Pisa, Italy.
  • Frassineti LG; Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.
  • Nicola S; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Piscaglia F; Medical Oncology Unit, IRCCS IstitutoTumori "Giovanni Paolo II" of Bari, Bari, Italy.
  • Kumada T; Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
  • Kim HD; Division of Internal Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Koga H; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Vivaldi C; Faculty of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
  • Soldà C; Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
  • Hiraoka A; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Bang Y; Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Pisa, Italy.
  • Atsukawa M; Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy.
  • Torimura T; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Tsuj K; Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
  • Itobayashi E; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Toyoda H; Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
  • Fukunishi S; Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
  • Rimassa L; Department of Gastroenterology, Asahi General Hospital, Asahi, Japan.
  • Rimini M; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Cascinu S; Second Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan.
  • Cucchetti A; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Liver Int ; 41(6): 1389-1397, 2021 06.
Article em En | MEDLINE | ID: mdl-33547848

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália País de publicação: Estados Unidos